Study Disputes Perception That New Beneficiaries Are Fueling Medicare Advantage Growth

The majority of people who signed up for Medicare Advantage plans in recent years were switching out of the traditional Medicare program, according to a recent study.

Read More

Why Drugs Cost So Much

ELI LILLY charges more than $13,000 a month for Cyramza, the newest drug to treat stomach cancer.

Read More

Aetna Backs Gilead’s Hepatitis C Treatment, Gets Discount

Aetna Inc, the third-largest U.S. health insurer, said it negotiated a discount with Gilead Sciences Inc for its hepatitis C treatment and will offer it as the preferred choice to nearly 11 million commercial customers.

Read More

California Rejects UnitedHealth’s Bid to Sell Obamacare Statewide

California's Obamacare exchange rejected a bid from the nation's largest health insurer to start selling coverage statewide next year.

Read More

Obamacare: Latino Enrollment Numbers in California Show Mixed Results

A retooled, multi-million-dollar marketing effort by the state's health care exchange to persuade more of the state's Latino residents to obtain insurance under the nation's health care law is showing mixed results, according to enrollment data released Thursday.

Read More

Insurers Bullish on Obamacare, Despite Supreme Court Uncertainty

As enrollment grows from the second year Americans can sign up for private coverage under the Affordable Care Act, health insurance companies are hinting at a 2015 that will also be lucrative to their bottom lines.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square